RBC Capital analyst Ben Hendrix maintained a Buy rating on Pennant Group (PNTG – Research Report) on March 11 and set a price target of $21.00. The company’s shares closed yesterday at $18.96.
Hendrix covers the Healthcare sector, focusing on stocks such as Cigna, Humana, and Universal Health. According to TipRanks, Hendrix has an average return of 3.8% and a 57.59% success rate on recommended stocks.
In addition to RBC Capital, Pennant Group also received a Buy from Oppenheimer’s Michael Wiederhorn in a report issued on March 1. However, on February 29, Truist Financial assigned a Hold rating to Pennant Group (NASDAQ: PNTG).
See Insiders’ Hot Stocks on TipRanks >>
Based on Pennant Group’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $140.19 million and a net profit of $4.38 million. In comparison, last year the company earned a revenue of $118.35 million and had a net profit of $4.83 million
Based on the recent corporate insider activity of 37 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of PNTG in relation to earlier this year. Earlier this month, John J Gochnour, the COO of PNTG bought 34,568.00 shares for a total of $116,148.48.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Pennant Group (PNTG) Company Description:
The Pennant Group, Inc. engages in the provision of healthcare services. It operates through the following segments: Home Health and Hospice Services, Senior Living Services, and All Other. The Home Health and Hospice Services segment provides combination of clinical care services such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services. The Senior Living Services segment deals with assisted and independent living and memory care businesses. The All Other segment includes mobile diagnostic and laboratory services. The company was founded on January 24, 2019 and is headquartered in Eagle, ID.
Read More on PNTG:
- Pennant Group to Participate in 2024 Healthcare Conference
- Pennant Group to Participate in the 2024 Oppenheimer Healthcare MedTech & Services Conference
- Pennant Acquires Two Senior Living Communities in Utah
- Pennant Group price target raised to $22 from $18 at Oppenheimer
- Pennant Group price target raised to $21 from $16 at Truist
